Today: 9 June 2026
Ucore Rare Metals stock slides 15% after metals rout — what to watch before Monday
31 January 2026
1 min read

Ucore Rare Metals stock slides 15% after metals rout — what to watch before Monday

Toronto, Jan 31, 2026, 13:13 EST — The market has closed.

  • Ucore Rare Metals dropped 14.6% on Friday, lagging as miners took a hit in a widespread risk-off wave.
  • A stronger U.S. dollar combined with profit-taking in precious metals weighed on prices as the month closed.
  • Traders are eyeing the dollar, rate expectations, and China’s February 16 holiday for clues on whether the selloff will extend into Monday.

Ucore Rare Metals (UCU.V) plunged 14.6% to C$8.36 on Friday, marking its steepest single-day drop in weeks. The selloff came as investors trimmed positions in small-cap materials stocks ahead of the month’s close.

This drop counts because Ucore acts like a high-beta stand-in for the “critical minerals” theme, which depends on steady funding and investor risk appetite. When macro shocks hit metals and miners, smaller, less liquid names usually feel the pinch first.

Canada’s main stock index tumbled 3.3% on Friday, dragged down by mining stocks following President Donald Trump’s nomination of Kevin Warsh to lead the Federal Reserve—seen by traders as a boost for the dollar. The gold sector plunged 11.8%, while the wider materials index dropped 10.5%.

A stronger U.S. dollar often pressures metals by pushing up prices for those paying in other currencies. This can dent demand slightly and trigger algorithmic selling once momentum falters.

Gold, silver, and copper tumbled sharply from record peaks on Friday, as investors cashed in gains and scaled back bets on aggressive U.S. rate cuts. “Both gold and silver were ripe for a correction,” said Ole Hansen of Saxo Bank. Panmure Liberum’s Tom Price cited profit-taking after the market absorbed Warsh’s appointment. Traders also pointed to the Lunar New Year holiday in China, starting February 16, as a near-term volatility trigger. Reuters

Ucore positions itself more as a processor than a miner, touting its rare earth separation tech, RapidSX, alongside plans for a processing facility in Louisiana. Such projects remain vulnerable to capital market swings, despite steady demand fundamentals.

In a January update reported by the trade press, the company set a mid-2026 goal to install its first commercial RapidSX machine at a converted site in Alexandria, Louisiana. It described the demonstration phase as a way to lower execution risks. Ucore executive Mike Schrider called the project a “de-risked commercialization pathway” aimed at launching heavy rare earth processing in Louisiana by 2026. Magnetics Magazine

The downside scenario is straightforward for now: if the dollar stays strong and metal prices continue to fall, funds might unload anything linked to the wider materials sector, no matter the specific project timelines. With thin liquidity, this could trigger a sharper decline than what fundamentals alone would indicate.

Monday’s open will reveal if Friday’s month-end selling cools off or spills into a follow-up sell-off. Traders will also zero in on the dollar and rate forecasts, along with positioning ahead of February 16, when China closes for a week-long Lunar New Year holiday.

Stock Market Today

  • Aker BP Share Price Surges Amid Valuation Debate
    June 9, 2026, 11:54 AM EDT. Aker BP (OB:AKRBP) shares climbed to NOK347.7, marking a 55.05% total shareholder return over one year, outperforming peers in Norway's energy sector. Despite this momentum, the stock trades at an 8.6% premium over a fair value of NOK320.11, raising questions about valuation. The company aims to sustain production above 500,000 barrels per day past 2030, backed by projects like Yggdrasil and Johan Sverdrup, supporting revenue growth. Yet, potential risks include higher emissions costs and delays in key developments. Analysts offer cautious pricing, but a discounted cash flow (DCF) model from Simply Wall St suggests a much higher intrinsic value of NOK1,769.75, indicating significant undervaluation. Investors face a valuation divide between conservative targets and optimistic cash flow projections.

Latest articles

Paranovus Stock Rockets 620% as $195 Million Share-Sale Filing Changes the Story

Paranovus Stock Rockets 620% as $195 Million Share-Sale Filing Changes the Story

9 June 2026
Paranovus Entertainment shares soared 620% to $6.76 after filing to potentially sell up to $195 million in new stock—an amount far exceeding its $7.14 million market cap—raising major dilution risks for investors as the company eyes acquisitions but warns that future share sales could pressure the stock price or threaten operations.
Coupang Stock Gains as Privacy Ruling Approaches

Coupang Stock Gains as Privacy Ruling Approaches

9 June 2026
Coupang shares jumped 2% to $15.49, outperforming a falling market, as investors braced for South Korea’s privacy regulator to decide June 10 on possible sanctions over a data breach exposing 33.6 million records—a ruling that could trigger fines up to 3% of sales and impact the stock’s recovery.
AEP’s $78 Billion Grid Plan Spurs Data Center Hopes

AEP’s $78 Billion Grid Plan Spurs Data Center Hopes

9 June 2026
AEP lifted its five-year capital plan to $78 billion after signing 7 gigawatts of new large-energy project agreements, with 90% of 63 gigawatts of expected incremental load by 2030 tied to data centers; shares recently traded at $127.27, up 26.9% over 52 weeks, with analysts’ mean price target at $142.76, as investors weigh execution risks and a new data-center rate structure.
Dow climbs in New York, but gains may stall

Dow climbs in New York, but gains may stall

9 June 2026
Dow jumps 154.87 points as tech rebounds and oil prices drop, with chipmakers like Intel and Broadcom up sharply; investors brace for Wednesday’s key inflation data and next week’s Fed meeting, which could sway rate expectations and market direction.
U.S. Stocks Hit Records This Week — Why the S&P 500 and Nasdaq Rally Survived the Oil Shock

Dow Up While Nasdaq Dips; AI Rally Meets Inflation Data

9 June 2026
Nuvalent soared after GSK agreed to buy the cancer drug developer for $10.6 billion in cash, valuing shares at $124—a 40% premium to Monday’s close—while investors awaited Wednesday’s key inflation data that could impact market direction and tech stock stability.
Gold price set for a bumpy week after historic slide from record highs
Previous Story

Gold price set for a bumpy week after historic slide from record highs

Quantum computing stocks tumble into weekend: IonQ, Rigetti, D-Wave slide as rate jitters bite
Next Story

Quantum computing stocks tumble into weekend: IonQ, Rigetti, D-Wave slide as rate jitters bite

Go toTop